Literature DB >> 27920655

Deep Vein Thrombosis as Initial Manifestation of Whipple Disease.

Mônica Souza de Miranda Henriques1, Alexandre Rolim da Paz1, Ana Beatriz Person Gaertner1, Cibelle Ingrid Stephen Melo1, Priscyanne Lins Filgueiras1, Rafaella Alencar Jerome1.   

Abstract

INTRODUCTION: Wipple disease (WD) is a rare chronic disease caused by the bacillus Tropheryma whipplei. Constitutive, rheumatologic, gastrointestinal, cardiac, cerebral, lymphatic, cutaneous, and ophthalmological signs are possible systemic symptoms. However, thrombotic manifestations are rarely described as "stroke-like syndrome" or arterial thrombosis. Diagnosis is based on clinical manifestations and pathological examination. Laboratory findings may include anemia, leukocytosis, and thrombocytosis.
OBJECTIVE: We report a case of venous thrombosis as initial manifestation of WD. CASE REPORT: We describe the case of a 53-year-old male with iliofemoral vein thrombosis followed by intermittent diarrhea, loss of appetite, abdominal distension, and bloating. A mild malnutrition state with a weight loss of 13 kg, pallor (+/4 +), presence of lower-limb edema (+/4 +), and hypertympanic distended abdomen occurred. Laboratory tests on admission revealed anemia, positive inflammatory activity tests, and normal coagulation. Endoscopic examination showed villous edema with white dotted infiltrates in the second duodenal portion and intestinal lymphangiectasia in the terminal ileum. Pathological examination revealed numerous macrophages with positive periodic acid-Schiff inclusions. Venous Doppler ultrasound showed extensive deep thrombosis on the left lower limb and recanalization of the femoral vein in the right lower limb. The patient was treated with ceftriaxone and enoxaparin sodium, which led to an improvement of gastrointestinal and thrombosis symptoms. COMMENTS: Hypercoagulability, endothelial damage, vasculitis, and blood stasis are present in T. whipplei infection, which are associated with the activation of inflammatory mechanisms as well as procoagulant and thromboembolic events. WD should be part of the differential diagnosis of diseases that cause venous thrombosis of unknown origin.

Entities:  

Keywords:  Thromboembolic events; Tropheryma whipplei; Vasculitis; Venous thrombosis; Whipple disease

Year:  2016        PMID: 27920655      PMCID: PMC5126608          DOI: 10.1159/000452206

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


Introduction

Wipple disease (WD) is characterized by a chronic, multisystem and recurrent infection caused by the gram-positive bacillus Tropheryma whipplei and recognized as important bacterial cause of malabsorption. It is a rare disease whose true incidence is unknown; some studies show an incidence of 1case/million. The occurrence is estimated to be approximately 12 cases per year [1, 2]. This disease mainly affects middle-aged Caucasian males from Europe and North America. Research has shown a higher prevalence among farmers because the bacillus has been found in the soil. T. whipplei can also be isolated from contaminated water, the oral cavity, and feces of healthy individuals [1, 2, 3]. The pathogenesis of WD is undetermined but appears to involve fecal-oral transmission of the bacillus. Host susceptibility, combined with a defect in cell-mediated immunity, involves the activation and interaction of macrophages with T cells, resulting in impaired phagocytosis and degradation of intracellular bacillus, allowing it to spread from the gastrointestinal tract. Although there is not a pattern of familial transmission in WD, some cases have been reported in relatives. More research is needed to clarify whether there are genetic changes that may predispose to this type of infection [1, 3]. The classic presentation consists of the triad of gastrointestinal symptoms diarrhea, weight loss, and malabsorption, which can be associated with systemic symptoms such as fever, joint pain, and neurological manifestations [4]. WD is a systemic disease with various clinical expressions, which affects in particular the small intestine. The classic disease can be divided into three phases: (a) nonspecific prodromal symptoms as arthritis, arthralgia, migratory polyarthralgia; (b) typical gastrointestinal symptoms such as diarrhea, weight loss, steatorrhea, and (c) malabsorption, which may progress to severe cachexia and abdominal lymphadenopathy. Some patients develop severe symptoms of malabsorption such as ascites and peripheral edema and generalized symptoms [3] such involvement of other organs, including heart, brain, lung, lymphatic, skin, and eye [1, 2, 5]. Hematological disorders may include anemia, leukocytosis, and thrombocytosis. However, thrombotic manifestations are poorly described in the literature, with rare reports of “stroke-like syndrome” or arterial thrombosis [6, 7]. The diagnosis should be based on clinical symptoms and pathology. In case of suspicion of WD, the immediate procedure is upper gastrointestinal endoscopy, whose most frequent findings are thickening of the mucosal folds with whitish, confluent exudates alternating with erosions and areas of friable mucosa. Histological examination, usually obtained by endoscopic duodenal biopsy, shows macrophagic infiltration containing microorganisms reactive to periodic acid Schiff (PAS). Polymerase chain reaction directed to bacterial sequences genome has high sensitivity and specificity and is indicated in atypical situations or when there is no histological confirmation. Furthermore, immunohistochemistry, the fluorescence in situ hybridization technique, culture, and serology are important tools that contribute to WD diagnosis [1]. Untreated WD can be fatal. There is good clinical and laboratory response to antibiotic therapy, although there is no consensus on the type, duration, and conduct for complications of the treatment regimen and also on how to treat serious neurological manifestations. Various treatments have been used empirically, including oral penicillins associated with streptomycins, tetracyclines, chloramphenicol, macrolides, and third-generation cephalosporins [1, 3]. The most important criterion for monitoring WD is clinical symptom improvement, which must occur during the first weeks after therapy. Follow-up investigations are recommended at 6 months, 12 months, and then yearly for at least 3 years, preferably throughout life at intervals of 2–3 years [5].

Case Presentation

A 53-year-old farmer had a brown-colored, painful edema and hyperemia of the left calf 2 years ago. At that time, he underwent venous ultrasound Doppler, which found right and left iliofemoral thrombosis that was treated conservatively. Sequentially, intermittent diarrhea, loss of appetite, abdominal pain and distension, flatulence, asthenia, and weight loss (13 kg) occurred. Symptomatic treatment was initiated, but symptoms persisted. The patient denied smoking and important family history. On examination, he weighed 47 kg (BMI 17.46) and had a mild malnutrition status, pallor (+/4 +), presence of lower-limb edema (+/4 +), and hypotrophic muscles. He had dermatitis ocher in the lower limbs, a palpable lymph node in the right anterior cervical region, and swelling in the left thigh. Laboratory tests on admission showed anemia (hemoglobin 9.0 g, hematocrit 28.8%), leukocytes 7.400 mm3 and 468,000 platelets, erythrocyte sedimentation rate 32 mm, C-reactive protein 48 mg/L, coagulation studies were normal, and coproculture and blood cultures were negative. Colonoscopy revealed terminal ileum lymphangiectasia, and esophagogastroduodenoscopy showed villous edema and white dotted infiltrates in the second duodenal portion (Fig 1a–d). Pathological examination revealed macrophagic infiltration containing microorganisms reactive to PAS (Fig 2, Fig 3). New venous Doppler pointed to extensive deep vein thrombosis of the left lower limb and recanalization signs of the femoral vein in the right lower limb. After treatment with ceftriaxone and enoxaparin, the patient has improved gastrointestinal symptoms with normalization of inflammatory activity tests and ultrasonographic signs of venous thrombosis.
Fig. 1

a–d Esophagogastroduodenoscopy with reduced duodenal folds, villous edema, and white dotted infiltrates in the second duodenal portion.

Fig. 2

Histopathology with histiocytes diffusely infiltrating the ileal mucosa. HE. ×200.

Fig. 3

Histopathology with foamy histiocytes stained by PAS in the duodenum. ×200.

Discussion

Hypercoagulability, endothelial damage and blood stasis are components of Virchow's triad [8, 9]. It is believed that at least 2 of the 3 factors when concomitant predispose to thrombus formation [10]. The most common diseases complicating thrombosis are cancers, systemic inflammation, sepsis, heart disease, protein-losing states, infectious diseases, and the use of a central venous catheter. Among these diseases, coagulation disorders, endogenous anticoagulants systems, fibrinolysis, and complement systems are documented [11]. In infectious states, inflammation is often accompanied by alteration of stasis or disturbance of the normal hemostatic balance by procoagulant and anticoagulant mechanisms characterized by biomarkers of inflammation, coagulation, and activation of monocytes [12, 13]. Studies comparing infected and uninfected patients suggest an association of this state with cardiovascular disease. Bacteria adhesion to a thrombogenic surface can assist in the pathophysiology and explain thromboembolic events associated with infection [10, 13]. Risk factors for venous thrombosis are well defined in medical reports. Age, male gender, smoking habits, family history of stroke, dyslipidemia, and infection are predisposing factors for thrombosis [11, 14, 15]. Thrombophilic phenomena in WD are consequent to T. whipplei infection with the activation of the inflammatory and coagulation cascade. This case report is particularly important because of its atypical presentation of venous thrombosis as initial sign of WD preceding gastrointestinal symptoms in 2 years. WD should be part of the differential diagnosis of diseases that cause venous thrombosis of unknown origin.

Statement of Ethics

The authors have no ethical conflicts to disclose.

Disclosure Statement

There are no potential conflicts of interest to disclose in association with this study.
  14 in total

1.  Cardiac Whipple's disease without digestive symptoms.

Authors:  C Elkins; T A Shuman; J S Pirolo
Journal:  Ann Thorac Surg       Date:  1999-01       Impact factor: 4.330

2.  Virchow's contribution to the understanding of thrombosis and cellular biology.

Authors:  David R Kumar; Erin Hanlin; Ingrid Glurich; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2010-08-25

3.  HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation.

Authors:  Kaku A Armah; Kathleen McGinnis; Jason Baker; Cynthia Gibert; Adeel A Butt; Kendall J Bryant; Matthew Goetz; Russell Tracy; Krisann K Oursler; David Rimland; Kristina Crothers; Maria Rodriguez-Barradas; Steve Crystal; Adam Gordon; Kevin Kraemer; Sheldon Brown; Mariana Gerschenson; David A Leaf; Steven G Deeks; Charles Rinaldo; Lewis H Kuller; Amy Justice; Matthew Freiberg
Journal:  Clin Infect Dis       Date:  2012-04-24       Impact factor: 9.079

Review 4.  Whipple's disease: new aspects of pathogenesis and treatment.

Authors:  Thomas Schneider; Verena Moos; Christoph Loddenkemper; Thomas Marth; Florence Fenollar; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

5.  A patient with cerebral Whipple's disease and a stroke-like syndrome.

Authors:  Giuseppe Famularo; Giovanni Minisola; Claudio De Simone
Journal:  Scand J Gastroenterol       Date:  2005-05       Impact factor: 2.423

Review 6.  Diseases associated with thrombosis.

Authors:  Armelle de Laforcade
Journal:  Top Companion Anim Med       Date:  2012-05

7.  Whipple's disease: rare disorder and late diagnosis.

Authors:  Viviane Plasse Renon; Marcelo Campos Appel-da-Silva; Rafael Bergesch D'Incao; Rodrigo Mayer Lul; Luciana Schmidt Kirschnick; Bruno Galperim
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2012 Sep-Oct       Impact factor: 1.846

8.  Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology.

Authors:  G Peters; D G du Plessis; P R Humphrey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

9.  Musculoskeletal Sepsis Associated with Deep Vein Thrombosis in a Child.

Authors:  Chih-Ying Lee; Yu-Sheng Lee; Pei-Chen Tsao; Mei-Jy Jeng; Wen-Jue Soong
Journal:  Pediatr Neonatol       Date:  2013-11-23       Impact factor: 2.083

10.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.